Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Benzelmin Equine Anthelmintic Oral Suspension 9.06 % Suspension is a Health Canada–registered veterinary drug (DIN 02231772) held by Ayerst Veterinary Laboratories, containing Oxfendazole. Health Canada lists its status as Cancelled Post Market (status date 23 Aug 2006). Nexara Health has matched 2 registrations of Oxfendazole across 1 other regulated market.

Health Canada registration

DIN02231772
Brand nameBenzelmin Equine Anthelmintic Oral Suspension
Active ingredientOxfendazole
Strength9.06 %
Dosage formSuspension
RouteOral
CompanyAyerst Veterinary Laboratories
StatusCancelled Post Market — 23 Aug 2006
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Oxfendazole registered in other markets

2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesOxfendazoleShaanxi Hanjiang Pharmaceutical Group Co., Ltd.PowderFDA NDC
United StatesOxfendazoleAlivira Animal Health LimitedPowderFDA NDC

See every manufacturer of Oxfendazole worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Benzelmin Equine Anthelmintic Oral Suspension (DIN 02231772) marketed in Canada?

No. Health Canada lists DIN 02231772 as Cancelled Post Market as of 23 Aug 2006.

Who holds the Canadian licence for this product?

Ayerst Veterinary Laboratories is the company of record in the Health Canada Drug Product Database.

Is Oxfendazole registered outside Canada?

Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02231772, status date 2006-08-23; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02231772, status date 2006-08-23; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02231772, status date 2006-08-23; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.